Comments

Madrigal Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MDGLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$313.47

-27.80-8.15%

At close: -

$313.47

0.000.00%

After Hours: 4:17 PM EDT

Q4 2024 Earnings were released on Wed Feb 26th, before the market open

The most recent conference call was at 8:00 AM, 6 days ago Click to view past webcast

Madrigal Pharmaceuticals (MDGL) Forecast

News Earnings Madrigal Pharmaceuticals (MDGL) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Madrigal Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:MDGL | Benzinga

Explore Madrigal Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDGL.

Open	$335.00
Close	$313.47
Volume / Avg.	524.12K / 385.44K
Day Range	$313.02 - $335.40
52 Wk Range	189.00 - 377.46
Market Cap	$6.92B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	24.54%
Days to Cover	10.7

Recent News

Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver Cirrhosis

Madrigal's Rezdiffra showed significant liver stiffness reduction in MASH cirrhosis. The company also beat Q4 earnings and revenue expectations.

Vandana Singh

Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon

Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ:MDGL), could bode well for Novo Nordisk A/S (NYSE:NVO). The pharma industry giant has seen explosive sales growth for its GLP-1 agonist drug,

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$335.00
Close	$313.47
Volume / Avg.	524.12K / 385.44K
Day Range	$313.02 - $335.40
52 Wk Range	189.00 - 377.46
Market Cap	$6.92B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	24.54%
Days to Cover	10.7

About Madrigal Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Madrigal Pharmaceuticals (MDGL) stock?

You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.

View our list of the best stock brokerages

Who are Madrigal Pharmaceuticals (MDGL) competitors?

Other companies in Madrigal Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Madrigal Pharmaceuticals (MDGL) stock?

Madrigal Pharmaceuticals has a consensus price target of $358.07.

What is the current price for Madrigal Pharmaceuticals (MDGL)?

The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $313.47 last updated March 3, 2025 at 4:17 PM EST.

Does Madrigal Pharmaceuticals (MDGL) pay a dividend?

There are no upcoming dividends for Madrigal Pharmaceuticals.

When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?

Madrigal Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Madrigal Pharmaceuticals (MDGL) going to split?

There is no upcoming split for Madrigal Pharmaceuticals.

What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.